Identification and mapping of Epstein-Barr virus early antigens and demonstration of a viral gene activator that functions in trans.
about
Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sitesGenome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expressionEpstein-Barr virus SM protein interacts with mRNA in vivo and mediates a gene-specific increase in cytoplasmic mRNA.Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes.Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R.Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders.Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA.Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replicationThe Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression.T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis.Regulation of the herpesvirus saimiri (HVS) delayed-early 110-kilodalton promoter by HVS immediate-early gene products and a homolog of the Epstein-Barr virus R trans activatorNegative regulation of the BZLF1 promoter of Epstein-Barr virus.The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R.Simian virus 40 T antigen alters the binding characteristics of specific simian DNA-binding factorsThe Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner.Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions.Herpes simplex virus alpha protein ICP27 possesses separable positive and negative regulatory activitiesThe Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent.The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivatorsRelative rates of RNA synthesis across the genome of Epstein-Barr virus are highest near oriP and oriLyt.Novel 12-O-tetradecanoylphorbol-13-acetate-responsive elements in the upstream sequence of the MS gene promoter of Epstein-Barr virus.Use of recombinant retroviruses to study the regulation of integrated adenovirus early promotersConservation of sequence and function between the product of the 52-kilodalton immediate-early gene of herpesvirus saimiri and the BMLF1-encoded transcriptional effector (EB2) of Epstein-Barr virus.Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity.Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter.Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.Association with the cellular export receptor CRM 1 mediates function and intracellular localization of Epstein-Barr virus SM protein, a regulator of gene expression.The Epstein-Barr virus SM protein induces STAT1 and interferon-stimulated gene expression.UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression.Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.Identification of proteins encoded by Epstein-Barr virus trans-activator genes.
P2860
Q28343493-AD47520B-941B-4DEE-9836-E1AB1A8BDF29Q33558271-B27E46E4-6FCC-4B71-A5D6-786AFFF6A700Q33565012-6DD044FC-28A1-4261-947D-D73761961038Q33688737-F405451D-3A87-4683-9027-1F4AC5BF18B8Q33796895-70D27D5D-6830-4096-87A5-E6D6420FC7ACQ33842488-AB2B9FE0-4195-4141-A9D5-1F95FA7BF2D5Q33903377-2A70B7F8-4A16-4B19-88C3-7516AA049CE8Q34601537-55679E65-3080-4898-88C6-87F327DF25F3Q35537283-991DBA5A-0F68-4110-931F-B1EB8BBB18DDQ35831688-35677167-4E89-4078-AD68-81C113F255DFQ35851194-D995159F-57E1-478B-8D37-5736B013CDE1Q35865903-58B57A29-541C-4341-9ACE-A1020F2D3CEBQ36224577-AA4922ED-761F-4BEF-BD5E-153416BC86ADQ36367545-CC08E787-D7B9-4A7F-B05C-9AC2814AE849Q36688920-10D14A84-9027-44E2-A952-BA6BB2D6CD86Q36701157-C1F9C7D9-693D-4B98-A1A1-902C0BF65AEDQ36780602-A3F01C46-E7F8-44C6-93C4-94A1DF72DDE3Q36780605-F6B8B3C9-10DB-4B4E-976B-C586C72AE79EQ36786812-06D53C35-0BE6-403A-90E5-B5BF03E7BE7BQ36792029-84E2A250-DDC3-416D-AA00-472828049346Q36802259-23B55B57-7A32-499B-A36A-D15B06B33D40Q36804236-46F238D1-2FA5-4E3C-8BCB-4F410C7AE297Q36812174-B30DDF79-1387-4984-96AB-28EC7E01F1A0Q36829336-6E39FD23-D4D1-4B44-96E0-63FC1B7D2BAFQ36829889-9920FE6A-0A4E-434B-9522-D11DAFA35DC6Q36830488-982DBB3F-3189-4DF0-88DA-88A9FFBBE862Q36830501-D76E8320-291E-4ADD-B58D-42C9CBBDAC5FQ36831849-CC6BA3CA-A635-4D46-AE6C-937114CD0707Q36832036-D4043AE8-1985-48B6-AD88-EB5D0949824BQ36869583-4A7F88EC-CE8C-4AF5-B474-D096AE1CB4CDQ36872354-F5C9EE6F-9812-4664-A5CB-0C1874F920D6Q36918907-4AA2BD66-A4D8-4580-AA69-69F61EEA0E67Q36919288-92993B19-D53A-4DB8-BD16-A14A69C85A1DQ36919739-624641DE-FC7A-4D2A-B5A0-8E119969A68DQ39595460-50E0355E-9721-410A-9F00-8EC52DCB7A64Q39732607-83FA77DF-ED50-4142-A5BB-F3197EC8136BQ40041085-87B5A912-161A-4EEF-9911-64969E4B3934Q40048036-965D3344-355C-44A6-90AA-A0FB1DAEC42BQ40100177-FA089E86-AE48-43F5-8CB0-80898024F858Q40100525-98C1967B-5FF3-47E7-BC4D-C46247410DB2
P2860
Identification and mapping of Epstein-Barr virus early antigens and demonstration of a viral gene activator that functions in trans.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Identification and mapping of ...... vator that functions in trans.
@en
type
label
Identification and mapping of ...... vator that functions in trans.
@en
prefLabel
Identification and mapping of ...... vator that functions in trans.
@en
P2860
P1433
P1476
Identification and mapping of ...... vator that functions in trans.
@en
P2093
P2860
P304
P407
P577
1986-10-01T00:00:00Z